Assessing the Risk Factors of Diabetes to Increase the Mortality Rate Due to Coronavirus (COVID-19) in United States

Authors

  • Henry Zeidan College of Graduate & Professional Studies, University of New England, Portland, USA.
  • Iman Zeidan McLaren Central Michigan, Medical Center and Central Michigan University, School of Medicine, MT, Pleasant, USA.
  • Laura Scholer-Bland Georgia Institute of Technology, Atlanta, USA.

DOI:

https://doi.org/10.9734/bpi/anums/v5/1768G

Keywords:

Middle east respiratory syndrome coronavirus (MERS-COVID) infection, risk factors, omicron virus, COVID-19 risk on children, interactions of independent variables, Poisson regression, linear regression

Abstract

This chapter highlights about risk factors of diabetes to increasing the mortality rate due to COVID 19. Diabetic patients are more likely to suffer from serious infection due to hyperglycemia, chronic inflammatory state, microcirculation damage and other factors. COVID-19 mortality combined with diabetes is still not clear. The duration, age, gender, race and blood glucose control of diabetes may have effect on the mortality of COVID-19. We conducted a thorough statistical analysis of numerous datasets, including COVID-19 infection and mortality rate, diabetes and diseases that may contribute to the severity and risk factor of diabetes in individuals and this impact on COVID-19 and the mortality rate, in an effort to understand the effect of diabetes on the increasing rate of infection with COVID-19. These diseases include respiratory diseases, cardiovascular diseases, and obesity. Equally significant is the statistical analysis on ethnicity, age, and sex on COVID-19 infection as well as mortality rate. Their possible contributions to increasing the severity and risk factor of diabetes as a risk to mortality to individuals who have COVID-19.

Published

2024-02-02

How to Cite

Henry Zeidan, Iman Zeidan, & Laura Scholer-Bland. (2024). Assessing the Risk Factors of Diabetes to Increase the Mortality Rate Due to Coronavirus (COVID-19) in United States. Advancement and New Understanding in Medical Science Vol. 5, 72–88. https://doi.org/10.9734/bpi/anums/v5/1768G